A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a ...
A new study headed by teams at the Wellcome Sanger Institute, EMBL’s European Bioinformatics Institute (EMBL-EBI), and Open Targets has indicated how mutations that cause cancer drug resistance fall ...
A family of mutations seen in about 20% of human cancers drives malignancy by changing the accessibility of genes to a ...
Mutations found in roughly 20% of human cancers may promote tumor growth by changing how DNA is organized inside cells.
A review in BMC Biology examines how advanced sequencing and computational tools detect ultra-rare somatic mutations and ...
Researchers published a new study, “Ongoing chromothripsis underpins osteosarcoma genome complexity and clonal evolution,” in Cell that they say solves the mystery of what drives the genomic ...
In a recent online publication in SCIENCE CHINA Life Sciences, researchers from the laboratory of Leng-Siew Yeap at the Shanghai Institute of Immunology, Shanghai Jiao Tong University School of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results